STEMCELL Technologies Signs Exclusive License to Commercialize Human Pluripotent Stem Cell-Derived Kidney Organoid Culture System

STEMCELL Technologies has today announced that they have signed an exclusive license agreement with Brigham and Women's Hospital for rights to commercialize technologies for the generation of human pluripotent stem cell-derived kidney organoids